RecruitingNCT06109857

Bladder Bank (a Prospective Banking Study)

Sponsor

Mayo Clinic

Enrollment

1,500 participants

Start Date

Jul 6, 2022

Study Type

OBSERVATIONAL

Conditions

Bladder Carcinoma

Summary

This study collects blood and urine samples from patients with bladder cancer to support the development of tests for early detection of bladder cancer.

Eligibility

Min Age: 18 Years

Inclusion Criteria2

Age \&gt; 18 years
Patient has undergone office-based evaluation for hematuria \[computed tomography (CT), ultrasound, cystoscopy\]

Exclusion Criteria10

Patient has known cancer outside of the target cancer 5 years prior to current collection (not including basal cell or squamous cell skin cancers; if patient has not been seen or if information is not available, the patient is eligible)
Patient has recurrent muscle invasive bladder cancer
Patient has ever been previously diagnosed with UTUC (upper tract urothelial carcinoma) prior to bladder resection
Patient has received chemotherapy class drugs for the treatment of non-target origin cancer in the 5 years prior to current collection
Patient has had any prior radiation therapy to the target lesion prior to current collection
Patient has had a biopsy to the target organ and/or lesion within 3 days before collection
Patient has undergone cystectomy or cystoprostatectomy
Patient has transurethral instrumentation (placement of urinary catheter) within 7 days prior to urine collection
Patient has had a urinary tract infection within 14 days prior to urine collection
Patient has chronic indwelling urinary catheter